OS Therapies Inc cotiza a 1.45 USD y tiene una capitalización bursátil de $68M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST…
| Periodo | 2026-11 | 2026-08 | 2026-08 | 2026-05 |
|---|---|---|---|---|
| Real | — | $-0.20 | — | $-0.27 |
| Estimado | $-0.12 | $-0.23 | $-0.21 | $-0.19 |
| Sorpresa | — | +13.0% | — | -42.1% |
| Métrica | OSTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -420.4% | -32.0% | -388.4% |
| Current Ratio | 0.03 | 2.84 | -2.81 |
| Debt / Equity | — | 0.28 | — |